Predictmedix AI, Inc. is a life sciences technology company, which engages in developing artificial intelligence (AI) powered technologies for general workplace health and safety, and for the health care industry. The company is headquartered in Toronto, Ontario. The company went IPO on 2019-12-20. The Company, through its subsidiaries, focuses on artificial intelligence (AI) technologies which target two specific areas: workplace health and safety and healthcare. The company has developed a technology for the identification and detection of infectious disease symptoms, including COVID-19, referred to as its infectious disease symptom screening solutions (IDSS) and marketed in North America under the name Safe Entry System. The company is also developing AI-powered products that address the detection of alcohol and/or cannabis impairment in individuals; mental illness screening, and remote patient monitoring and treatment plans, referred to as the Mobile Wellbeing product. The company is adding additional modules to this Mobile Wellbeing platform that help to use a patient’s history and real-time medical data, such as blood pressure, and to provide patients and their medical professionals with treatment plans for chronic disease management.
최신 재무제표(Form-10K)에 따르면, Sachem Capital Corp의 총 자산은 $0이며, 순손실입니다.
PMEDF의 주요 재무 비율은 무엇인가요?
Sachem Capital Corp의 유동비율은 0이고, 순이익률은 0, 주당 매출은 $0입니다.
QScreen AI Inc.의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Sachem Capital Corp 주요 수익원은 Real Estate Investment Trust이며, 최신 수익 발표에서 수익은 64,773,320입니다. 지역별로는 United States이 Sachem Capital Corp의 주요 시장이며, 수익은 64,773,320입니다.